1. K-Ras-independent effects of the farnesyl transferase inhibitor L-744,832 on cyclin B1/Cdc2 kinase activity, G2/M cell cycle progression and apoptosis in human pancreatic ductal adenocarcinoma cells. Song SY, Meszoely IM, Coffey RJ, Pietenpol JA, Leach SD (2000) Neoplasia 2(3): 261-72
    › Primary publication · 10935512 (PubMed) · PMC1507570 (PubMed Central)
  2. Crk-associated substrate p130(Cas) interacts with nephrocystin and both proteins localize to cell-cell contacts of polarized epithelial cells. Donaldson JC, Dempsey PJ, Reddy S, Bouton AH, Coffey RJ, Hanks SK (2000) Exp Cell Res 256(1): 168-78
    › Primary publication · 10739664 (PubMed)
  3. Blockade of the epidermal growth factor receptor tyrosine kinase suppresses tumorigenesis in MMTV/Neu + MMTV/TGF-alpha bigenic mice. Lenferink AE, Simpson JF, Shawver LK, Coffey RJ, Forbes JT, Arteaga CL (2000) Proc Natl Acad Sci U S A 97(17): 9609-14
    › Primary publication · 10931950 (PubMed) · PMC16912 (PubMed Central)
  4. Treatment with farnesyl-protein transferase inhibitor induces regression of mammary tumors in transforming growth factor (TGF) alpha and TGF alpha/neu transgenic mice by inhibition of mitogenic activity and induction of apoptosis. Nørgaard P, Law B, Joseph H, Page DL, Shyr Y, Mays D, Pietenpol JA, Kohl NE, Oliff A, Coffey RJ, Poulsen HS, Moses HL (1999) Clin Cancer Res 5(1): 35-42
    › Primary publication · 9918200 (PubMed)
  5. Prostaglandin J2 and 15-deoxy-delta12,14-prostaglandin J2 induce proliferation of cyclooxygenase-depleted colorectal cancer cells. Chinery R, Coffey RJ, Graves-Deal R, Kirkland SC, Sanchez SC, Zackert WE, Oates JA, Morrow JD (1999) Cancer Res 59(11): 2739-46
    › Primary publication · 10364000 (PubMed)
  6. Pharmacological inhibition of Ras-transformed epithelial cell growth is linked to down-regulation of epidermal growth factor-related peptides. Sizemore N, Cox AD, Barnard JA, Oldham SM, Reynolds ER, Der CJ, Coffey RJ (1999) Gastroenterology 117(3): 567-76
    › Primary publication · 10464132 (PubMed)
  7. Expansion of Pdx1-expressing pancreatic epithelium and islet neogenesis in transgenic mice overexpressing transforming growth factor alpha. Song SY, Gannon M, Washington MK, Scoggins CR, Meszoely IM, Goldenring JR, Marino CR, Sandgren EP, Coffey RJ, Wright CV, Leach SD (1999) Gastroenterology 117(6): 1416-26
    › Primary publication · 10579983 (PubMed)
  8. Amphiregulin acts as an autocrine growth factor in two human polarizing colon cancer lines that exhibit domain selective EGF receptor mitogenesis. Damstrup L, Kuwada SK, Dempsey PJ, Brown CL, Hawkey CJ, Poulsen HS, Wiley HS, Coffey RJ (1999) Br J Cancer 80(7): 1012-9
    › Primary publication · 10362109 (PubMed) · PMC2363033 (PubMed Central)
  9. Increased intestinal epithelial proliferation in metallothioneine-transforming growth factor alpha transgenic mice. Acra SA, Bulus N, Bogatcheva G, Coffey RJ, Barnard JA (1998) Regul Pept 74(2-3): 105-12
    › Primary publication · 9712170 (PubMed)
  10. Identification of rCop-1, a new member of the CCN protein family, as a negative regulator for cell transformation. Zhang R, Averboukh L, Zhu W, Zhang H, Jo H, Dempsey PJ, Coffey RJ, Pardee AB, Liang P (1998) Mol Cell Biol 18(10): 6131-41
    › Primary publication · 9742130 (PubMed) · PMC109199 (PubMed Central)